Russian Sovereign Fund Rusnano Invests $20 Million In CoDa Therapeutics
This article was originally published in PharmAsia News
Executive Summary
Wound healing company CoDa Therapeutics is the first Domain portfolio company to benefit from the venture capital firm’s new, $760 million partnership with Russian sovereign fund Rusnano.